• Amylyx Pharma's IPO lands $190M as ALS drug begins FDA review

    14 days ago - By MedCity News

    It's the first week of the new year, and the life sciences sector continued the IPO momentum of 2021 as Wall Street welcomed three new biotech companies. Here's a look at the IPOs of Amylyx Pharmaceuticals, CinCor, and Vigil Neuroscience, which raised a combined $482 million to support work on drugs addressing neurodegenerative and cardiovascular disorders.
    Read more ...